Tafamidis Cuts Cardiovascular Death and Hospitalization Risk for Up to 90 Months
A post hoc analysis of the ATTR-ACT trial and its long-term extension found continuous tafamidis treatment significantly reduced cardiovascular death ...
Tag: long-term cardiovascular risk reduction
GLP-1 Agonists Show Promise in Stopping Prediabetes Before Diabetes Strikes
The blockbuster medications behind the Ozempic revolution may be able to stop type 2 diabetes before it ever begins. A ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!